Tajima Hiroyuki, Kaneshiro Tadashi, Takenoshita Naoko, Ichikawa Taro, Isshiki Saiko, Murata Satoru, Onozawa Shiro, Nakazawa Ken
Center for Minimally Invasive Treatment, Nippon Medical School Musashikosugi Hospital, Kawasaki, Kanagawa, Japan.
Department of Radiology, Nippon Medical School Musashikosugi Hospital, Kawasaki, Kanagawa, Japan.
Ann Vasc Dis. 2017 Dec 25;10(4):338-344. doi: 10.3400/avd.ra.17-00082.
Treatment for venous thromboembolic conditions differs significantly depending on whether the condition is acute or chronic. Endovenous treatment is now available for treating the most severe cases of acute massive pulmonary thromboembolism, and the goal is rapid central clot removal to relieve life-threatening pulmonary circulation. Endovenous catheter interventions include catheter-directed thrombolysis and catheter-assisted thrombus removal. The latter is divided into aspiration thrombectomy, fragmentation, and rheolytic thrombectomy. Data from cohort studies indicate that the clinical outcome and safety after open surgical treatment and endovenous treatment may be comparable. This paper reviews the current approaches to endovenous treatment for acute massive pulmonary thromboembolism, and presents our study of hybrid treatment using a combination of local fibrinolysis, mechanical fragmentation, and clot aspiration.
静脉血栓栓塞性疾病的治疗因病情是急性还是慢性而有显著差异。目前可采用静脉内治疗来处理急性大面积肺血栓栓塞最严重的病例,目标是迅速清除中心血栓以缓解危及生命的肺循环。静脉内导管干预措施包括导管导向溶栓和导管辅助血栓清除。后者又分为抽吸血栓切除术、血栓破碎术和机械性血栓溶解术。队列研究数据表明,开放手术治疗和静脉内治疗后的临床结局和安全性可能相当。本文综述了目前急性大面积肺血栓栓塞的静脉内治疗方法,并介绍了我们采用局部纤溶、机械破碎和血栓抽吸相结合的综合治疗研究。